{"gene":"SZT2","run_date":"2026-06-10T10:51:54","timeline":{"discoveries":[{"year":2017,"finding":"SZT2 recruits a fraction of GATOR1 and GATOR2 to form a SZT2-orchestrated GATOR (SOG) complex; the SZT2-GATOR1 and SZT2-GATOR2 interactions are synergistic, and an intact SOG complex is required for lysosomal localization of GATOR components. SZT2 deficiency results in constitutive mTORC1 signaling under nutrient-deprived conditions. Hyperactivation of mTORC1 in SZT2-deficient cells was partially corrected by overexpression of DEPDC5, lysosome-targeted WDR59, or lysosome-targeted SESN2, placing SZT2 upstream of GATOR1/2 and SESN in nutrient sensing.","method":"Co-immunoprecipitation, lysosome fractionation, genetic rescue (overexpression of GATOR1/GATOR2/SESN2 components), mouse knockout (neonatal lethality with failure to inactivate mTORC1 during fasting), cell-based mTORC1 activity assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, lysosomal fractionation, genetic epistasis with multiple components, in vivo mouse model, multiple orthogonal methods in one rigorous study","pmids":["28199315"],"is_preprint":false},{"year":2009,"finding":"Szt2 is a large (~378 kDa) protein encoded by a 72-exon gene with no significant sequence similarity to other proteins; a splice-donor mutation after exon 32 causes transcriptional read-through and premature stop, conferring low seizure threshold in mice. A gene-trap mutation in exon 21 also conferred low seizure threshold and some embryonic lethality in homozygotes, indicating a developmental role. Szt2 is highly expressed in brain and is evolutionarily conserved across land vertebrates and many invertebrates.","method":"Chemical mutagenesis screen, genetic mapping, RT-PCR (splice mutation verification), gene-trap allele phenotypic analysis","journal":"Genes, brain, and behavior","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — forward genetic screen with two independent alleles, RT-PCR validation, phenotypic characterization; no biochemical mechanism established","pmids":["19624305"],"is_preprint":false},{"year":2019,"finding":"Patient-derived lymphoblastoid cell lines (LCLs) carrying biallelic SZT2 loss-of-function mutations show increased phosphorylation of S6K and S6 under amino acid starvation, and constitutive lysosomal localization of mTOR, demonstrating that SZT2 mutations cause hyperactivation of mTORC1 in human cells. Patients' LCLs also display excessive mTORC1 response to slight amino acid stimulation.","method":"Phospho-immunoblotting (pS6K, pS6), immunofluorescence for lysosomal mTOR localization in patient-derived LCLs under amino acid starvation and stimulation conditions","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — patient-derived cell functional assay with two orthogonal readouts (phosphoblot + lysosomal localization), single lab","pmids":["31430354"],"is_preprint":false},{"year":2022,"finding":"SZT2 is required for hematopoietic stem cell (HSC) homeostasis through nutrient-mediated mTORC1 regulation. HSC-specific SZT2 ablation decreased the HSC reserve and impaired repopulating capacity. Simultaneous ablation of SZT2 and TSC1 produced a synergistic (~10-fold) increase in mTORC1 activity and ~100-fold increase in ROS production, rapidly depleting HSCs, causing pancytopenia and premature mouse death, demonstrating that nutrient-sensing (SZT2) and growth-factor-sensing (TSC1) arms of mTORC1 regulation act synergistically in stem cells.","method":"Conditional HSC-specific knockout mice, bone marrow transplantation (repopulating capacity assay), phospho-S6K/S6 immunoblotting, ROS measurement, double-knockout epistasis analysis","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with functional readout (repopulating assay), double-KO epistasis, multiple biochemical readouts, in vivo model","pmids":["36250465"],"is_preprint":false},{"year":2022,"finding":"A functional mTORC1 assay identified SZT2 p.Val1984del as a loss-of-function variant; haplotype analysis revealed it is a founder variant in individuals of Ashkenazi Jewish ancestry. The assay platform was used to reclassify variants of uncertain significance in SZT2, confirming the protein's role in the amino acid-sensing arm of mTORC1 signaling.","method":"Cell-based mTORC1 signaling functional assay (phospho-S6K readout in SZT2-null cells re-expressing variants), haplotype analysis","journal":"Brain : a journal of neurology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-based functional assay with defined readout for multiple variants, single lab","pmids":["35773235"],"is_preprint":false},{"year":2021,"finding":"Systematic interactome analysis of SZT2 identified interaction partners beyond known GATOR/KICSTOR components, including proteins related to autophagy, ciliogenesis regulation, neurogenesis, and neurodegenerative processes. SZT2 KO cells showed increased mTORC1 signaling (reversible by Rapamycin or Torin) and elevated autophagic component levels independent of nutrient conditions. Preliminary data indicated SZT2 alters ciliogenesis.","method":"Affinity purification/mass spectrometry interactome analysis under catabolic and anabolic conditions, SZT2 KO cell lines with mTORC1 and autophagy marker immunoblotting, ciliogenesis assay","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — AP-MS interactome with functional validation in KO cells using multiple readouts; ciliogenesis described as preliminary, single lab","pmids":["34685691"],"is_preprint":false},{"year":2018,"finding":"Patient-derived compound heterozygous Szt2 variants impair mitochondrial energy metabolism, providing the first evidence of a metabolic consequence of SZT2 loss of function beyond mTOR signaling.","method":"Metabolic profiling / mitochondrial energy metabolism assays in patient-derived cells","journal":"Clinical case reports","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single patient case, single lab, abstract does not detail specific methods or controls beyond 'metabolic profiling'","pmids":["30564332"],"is_preprint":false},{"year":2026,"finding":"In human brain organoids derived from SZT2 mutant iPSCs, there is a significantly greater number of outer radial glial cells (oRGCs) in the SVZ-like layer and more upper-layer neurons compared to controls. SZT2 mutant organoids show higher mTORC1 activity in the SVZ, suggesting SZT2 dysfunction causes cortical expansion (and potentially macrocephaly) through mTORC1 dysregulation in neural stem/progenitor cells.","method":"iPSC-derived brain organoids from SZT2 patient lines, immunostaining for oRGC markers, mTORC1 activity readouts in SVZ-like regions","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — human organoid model with defined cellular phenotype and mTORC1 mechanistic link, single lab, new study","pmids":["41535455"],"is_preprint":false},{"year":2022,"finding":"Crystal structure simulation analysis of SZT2 missense variant c.3508A>G/p.Ser1170Gly predicted impaired binding of SZT2 to GATOR1, suggesting the Ser1170 residue is important for SZT2–GATOR1 interaction and that disruption leads to mTORC1 overactivation.","method":"In silico crystal structure simulation/molecular modeling of SZT2 missense variants","journal":"Neurological sciences","confidence":"Low","confidence_rationale":"Tier 4 / Weak — computational prediction only, no experimental validation of interaction reported in abstract","pmids":["35352205"],"is_preprint":false}],"current_model":"SZT2 is a large scaffolding protein that forms the core of the KICSTOR complex and assembles a SZT2-orchestrated GATOR (SOG) complex by simultaneously recruiting GATOR1 (a GAP for RagA/B GTPases) and GATOR2 to lysosomes, thereby enabling nutrient-sensitive downregulation of mTORC1; loss of SZT2 causes constitutive lysosomal mTOR localization and mTORC1 hyperactivation under amino acid deprivation, with demonstrated consequences in neurons (excess outer radial glia, cortical over-expansion), hematopoietic stem cells (impaired self-renewal, synergistic ROS elevation with TSC1 loss), and patient-derived lymphoblastoid cells, placing SZT2 as the critical upstream organizer of the amino acid–sensing branch of mTORC1 signaling."},"narrative":{"mechanistic_narrative":"SZT2 is a large scaffolding protein that organizes the amino acid-sensing branch of mTORC1 signaling by assembling a SZT2-orchestrated GATOR (SOG) complex, simultaneously recruiting GATOR1 and GATOR2 to lysosomes through synergistic interactions that are required for the lysosomal localization of GATOR components [PMID:28199315]. Loss of SZT2 produces constitutive mTORC1 signaling even under nutrient-deprived conditions, and this hyperactivation can be corrected by restoring downstream nutrient-sensing components such as DEPDC5, lysosome-targeted WDR59, or lysosome-targeted SESN2, placing SZT2 upstream of GATOR1/2 and SESN [PMID:28199315]. In human cells, biallelic SZT2 loss-of-function leads to constitutive lysosomal mTOR localization and elevated S6K/S6 phosphorylation under amino acid starvation, with exaggerated responses to slight amino acid stimulation [PMID:31430354], and cell-based functional assays have validated specific pathogenic variants and reclassified variants of uncertain significance in this pathway [PMID:35773235]. The consequences of this regulatory role are evident across cell types: SZT2 sustains hematopoietic stem cell homeostasis and self-renewal, acting synergistically with the growth-factor-sensing arm (TSC1) such that combined loss drives a ~10-fold increase in mTORC1 activity, ~100-fold increase in ROS, and rapid stem cell depletion [PMID:36250465], and in human brain organoids SZT2 mutation elevates mTORC1 activity in the SVZ and expands outer radial glia and upper-layer neurons, linking SZT2 dysregulation to cortical over-expansion [PMID:41535455]. SZT2 was originally identified as a brain-enriched, evolutionarily conserved protein whose mutation confers a low seizure threshold in mice [PMID:19624305]. Beyond its core mTORC1 role, interactome analysis has linked SZT2 to autophagy regulation and ciliogenesis [PMID:34685691].","teleology":[{"year":2009,"claim":"Before any biochemical role was known, forward genetics established SZT2 as a brain-enriched, conserved protein whose disruption alters neuronal excitability, framing it as a developmentally important gene.","evidence":"Chemical mutagenesis screen and gene-trap alleles in mice with genetic mapping and RT-PCR validation","pmids":["19624305"],"confidence":"Medium","gaps":["No molecular mechanism or biochemical activity established","No protein interaction partners identified","Link to mTORC1 not yet known"]},{"year":2017,"claim":"The central question of what SZT2 does molecularly was answered by showing it scaffolds GATOR1 and GATOR2 into a lysosomal SOG complex, defining SZT2 as the upstream organizer of amino acid-sensing input to mTORC1.","evidence":"Reciprocal co-IP, lysosome fractionation, genetic epistasis rescue with GATOR/SESN components, and mouse knockout with fasting-resistant mTORC1 activity","pmids":["28199315"],"confidence":"High","gaps":["No high-resolution structure of the SOG complex","Stoichiometry and assembly order of SZT2-GATOR1-GATOR2 not resolved","Mechanism of nutrient signal transduction through the scaffold unclear"]},{"year":2018,"claim":"A first hint that SZT2 loss has consequences beyond mTOR signaling came from a metabolic readout, raising the possibility of a mitochondrial energy role.","evidence":"Metabolic profiling / mitochondrial energy metabolism assays in patient-derived cells","pmids":["30564332"],"confidence":"Low","gaps":["Single patient case without detailed methods or controls","Causal link between SZT2 and mitochondrial metabolism not established","Not independently replicated"]},{"year":2019,"claim":"The mouse and cell-line mechanism was confirmed to operate in human disease by demonstrating constitutive lysosomal mTOR and elevated S6K/S6 phosphorylation in patient-derived cells carrying biallelic SZT2 mutations.","evidence":"Phospho-immunoblotting and immunofluorescence for lysosomal mTOR in patient LCLs under starvation and stimulation","pmids":["31430354"],"confidence":"Medium","gaps":["Single-lab patient-derived cell study","Does not resolve which protein interactions are disrupted by specific mutations","Does not connect cellular phenotype to organismal disease features"]},{"year":2021,"claim":"Unbiased interactome mapping extended SZT2's reach beyond GATOR/KICSTOR, implicating it in autophagy and ciliogenesis while confirming nutrient-independent mTORC1 control in knockout cells.","evidence":"AP-MS interactome under catabolic/anabolic conditions plus mTORC1 and autophagy marker immunoblotting and ciliogenesis assays in KO cells","pmids":["34685691"],"confidence":"Medium","gaps":["Ciliogenesis effect described as preliminary","Functional significance of non-GATOR interactors not validated","Single lab"]},{"year":2022,"claim":"Cell-based functional assays operationalized the mechanism for clinical genetics, identifying loss-of-function variants (including an Ashkenazi Jewish founder allele) and reclassifying variants of uncertain significance.","evidence":"Phospho-S6K readout in SZT2-null cells re-expressing variants, with haplotype analysis; complemented by in silico structural modeling of a GATOR1-binding residue","pmids":["35773235","35352205"],"confidence":"Medium","gaps":["Structural prediction of Ser1170 GATOR1 binding not experimentally validated","Variant assay reflects S6K readout only, not full pathway","Genotype-phenotype correlation across variants incomplete"]},{"year":2022,"claim":"Tissue-specific genetics revealed that SZT2 nutrient sensing is functionally critical in stem cells and acts synergistically with the growth-factor arm, defining how two mTORC1 inputs integrate physiologically.","evidence":"HSC-specific conditional knockout with bone marrow repopulation assays, SZT2/TSC1 double-KO epistasis, phospho-S6K/S6 immunoblotting, and ROS measurement","pmids":["36250465"],"confidence":"High","gaps":["Molecular basis of synergy with TSC1 not defined biochemically","Source of the dramatic ROS elevation not mechanistically dissected","Generalizability beyond HSCs unaddressed"]},{"year":2026,"claim":"Human brain organoids connected SZT2-driven mTORC1 dysregulation to a specific neurodevelopmental phenotype, linking progenitor mTORC1 hyperactivity to outer radial glia expansion and cortical over-growth.","evidence":"iPSC-derived brain organoids from SZT2 patient lines with oRGC marker immunostaining and mTORC1 activity readouts in SVZ-like regions","pmids":["41535455"],"confidence":"Medium","gaps":["Single-lab organoid model","Causal chain from mTORC1 to oRGC expansion not fully dissected","Relationship to human macrocephaly remains inferential"]},{"year":null,"claim":"How SZT2 transduces nutrient signals through the SOG scaffold at atomic resolution, and whether its autophagy, ciliogenesis, and mitochondrial links are direct or downstream of mTORC1, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No experimental structure of SZT2 or the SOG complex","Direct versus indirect basis of non-mTOR functions unknown","Mechanism coupling amino acid status to GATOR1/2 regulation undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0]}],"localization":[{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[0,2]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,3]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[5]}],"complexes":["KICSTOR","SZT2-orchestrated GATOR (SOG) complex"],"partners":["DEPDC5","WDR59","SESN2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q5T011","full_name":"KICSTOR complex protein SZT2","aliases":["Seizure threshold 2 protein homolog"],"length_aa":3432,"mass_kda":378.0,"function":"As part of the KICSTOR complex functions in the amino acid-sensing branch of the TORC1 signaling pathway. Recruits, in an amino acid-independent manner, the GATOR1 complex to the lysosomal membranes and allows its interaction with GATOR2 and the RAG GTPases. Functions upstream of the RAG GTPases and is required to negatively regulate mTORC1 signaling in absence of amino acids. In absence of the KICSTOR complex mTORC1 is constitutively localized to the lysosome and activated. The KICSTOR complex is also probably involved in the regulation of mTORC1 by glucose (PubMed:28199306, PubMed:28199315). May play a role in the cellular response to oxidative stress (By similarity)","subcellular_location":"Lysosome membrane; Peroxisome","url":"https://www.uniprot.org/uniprotkb/Q5T011/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SZT2","classification":"Not Classified","n_dependent_lines":24,"n_total_lines":1208,"dependency_fraction":0.019867549668874173},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SZT2","total_profiled":1310},"omim":[{"mim_id":"621100","title":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 83; MRT83","url":"https://www.omim.org/entry/621100"},{"mim_id":"617421","title":"INTEGRIN-ALPHA FG-GAP REPEAT-CONTAINING PROTEIN 2; ITFG2","url":"https://www.omim.org/entry/617421"},{"mim_id":"617420","title":"KICSTOR SUBUNIT 2; KICS2","url":"https://www.omim.org/entry/617420"},{"mim_id":"617418","title":"WD REPEAT-CONTAINING PROTEIN 59; WDR59","url":"https://www.omim.org/entry/617418"},{"mim_id":"615620","title":"KAPTIN; KPTN","url":"https://www.omim.org/entry/615620"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Vesicles","reliability":"Approved"},{"location":"Actin filaments","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/SZT2"},"hgnc":{"alias_symbol":["FLJ10387","SZT2B","RP11-506B15.1","FLJ34502","SZT2A","KICS1"],"prev_symbol":["C1orf84","KIAA0467"]},"alphafold":{"accession":"Q5T011","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q5T011","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q5T011-7-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q5T011-7-F1-predicted_aligned_error_v6.png","plddt_mean":83.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SZT2","jax_strain_url":"https://www.jax.org/strain/search?query=SZT2"},"sequence":{"accession":"Q5T011","fasta_url":"https://rest.uniprot.org/uniprotkb/Q5T011.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q5T011/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q5T011"}},"corpus_meta":[{"pmid":"28199315","id":"PMC_28199315","title":"SZT2 dictates GATOR control of mTORC1 signalling.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28199315","citation_count":159,"is_preprint":false},{"pmid":"23932106","id":"PMC_23932106","title":"Biallelic SZT2 mutations cause infantile encephalopathy with epilepsy and dysmorphic corpus callosum.","date":"2013","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23932106","citation_count":68,"is_preprint":false},{"pmid":"19624305","id":"PMC_19624305","title":"Szt2, a novel gene for seizure threshold in mice.","date":"2009","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/19624305","citation_count":49,"is_preprint":false},{"pmid":"27248490","id":"PMC_27248490","title":"Early-life epileptic encephalopathy secondary to SZT2 pathogenic recessive variants.","date":"2016","source":"Epileptic disorders : international epilepsy journal with videotape","url":"https://pubmed.ncbi.nlm.nih.gov/27248490","citation_count":27,"is_preprint":false},{"pmid":"28556953","id":"PMC_28556953","title":"Novel biallelic SZT2 mutations in 3 cases of early-onset epileptic encephalopathy.","date":"2017","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28556953","citation_count":24,"is_preprint":false},{"pmid":"29696782","id":"PMC_29696782","title":"Mutations in SZT2 result in early-onset epileptic encephalopathy and leukoencephalopathy.","date":"2018","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/29696782","citation_count":17,"is_preprint":false},{"pmid":"32402703","id":"PMC_32402703","title":"Developmental and epileptic encephalopathy due to SZT2 genomic variants: Emerging features of a syndromic condition.","date":"2020","source":"Epilepsy & behavior : E&B","url":"https://pubmed.ncbi.nlm.nih.gov/32402703","citation_count":16,"is_preprint":false},{"pmid":"30315519","id":"PMC_30315519","title":"A novel homozygous mutation in SZT2 gene in Saudi family with developmental delay, macrocephaly and epilepsy.","date":"2018","source":"Genes & genomics","url":"https://pubmed.ncbi.nlm.nih.gov/30315519","citation_count":15,"is_preprint":false},{"pmid":"37213690","id":"PMC_37213690","title":"SZT2 variants associated with partial epilepsy or epileptic encephalopathy and the genotype-phenotype correlation.","date":"2023","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/37213690","citation_count":14,"is_preprint":false},{"pmid":"30818181","id":"PMC_30818181","title":"Compound heterozygous SZT2 mutations in two siblings with early-onset epilepsy, intellectual disability and macrocephaly.","date":"2018","source":"Seizure","url":"https://pubmed.ncbi.nlm.nih.gov/30818181","citation_count":14,"is_preprint":false},{"pmid":"31430354","id":"PMC_31430354","title":"Constitutive activation of mTORC1 signaling induced by biallelic loss-of-function mutations in SZT2 underlies a discernible neurodevelopmental disease.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/31430354","citation_count":13,"is_preprint":false},{"pmid":"31397114","id":"PMC_31397114","title":"Novel SZT2 mutations in three patients with developmental and epileptic encephalopathies.","date":"2019","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31397114","citation_count":12,"is_preprint":false},{"pmid":"30359774","id":"PMC_30359774","title":"SZT2 mutation in a boy with intellectual disability, seizures and autistic features.","date":"2018","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30359774","citation_count":11,"is_preprint":false},{"pmid":"30564332","id":"PMC_30564332","title":"Novel metabolic signatures of compound heterozygous Szt2 variants in a case of early-onset of epileptic encephalopathy.","date":"2018","source":"Clinical case reports","url":"https://pubmed.ncbi.nlm.nih.gov/30564332","citation_count":11,"is_preprint":false},{"pmid":"36250465","id":"PMC_36250465","title":"SZT2 maintains hematopoietic stem cell homeostasis via nutrient-mediated mTORC1 regulation.","date":"2022","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/36250465","citation_count":10,"is_preprint":false},{"pmid":"30560016","id":"PMC_30560016","title":"Identification of a rare homozygous SZT2 variant due to uniparental disomy in a patient with a neurodevelopmental disorder.","date":"2018","source":"Intractable & rare diseases research","url":"https://pubmed.ncbi.nlm.nih.gov/30560016","citation_count":10,"is_preprint":false},{"pmid":"35773235","id":"PMC_35773235","title":"mTORC1 functional assay reveals SZT2 loss-of-function variants and a founder in-frame deletion.","date":"2022","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/35773235","citation_count":9,"is_preprint":false},{"pmid":"39572656","id":"PMC_39572656","title":"A novel hypoxia-induced lncRNA, SZT2-AS1, boosts HCC progression by mediating HIF heterodimerization and histone trimethylation under a hypoxic microenvironment.","date":"2024","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/39572656","citation_count":9,"is_preprint":false},{"pmid":"34685691","id":"PMC_34685691","title":"The SZT2 Interactome Unravels New Functions of the KICSTOR Complex.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/34685691","citation_count":9,"is_preprint":false},{"pmid":"33681650","id":"PMC_33681650","title":"A novel possible familial cause of epilepsy of infancy with migrating focal seizures related to SZT2 gene variant.","date":"2021","source":"Epilepsia open","url":"https://pubmed.ncbi.nlm.nih.gov/33681650","citation_count":6,"is_preprint":false},{"pmid":"32723703","id":"PMC_32723703","title":"Biallelic SZT2 variants in a child with developmental and epileptic encephalopathy.","date":"2020","source":"Epileptic disorders : international epilepsy journal with videotape","url":"https://pubmed.ncbi.nlm.nih.gov/32723703","citation_count":4,"is_preprint":false},{"pmid":"37760843","id":"PMC_37760843","title":"Insight into Genetic Mutations of SZT2: Is It a Syndrome?","date":"2023","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/37760843","citation_count":3,"is_preprint":false},{"pmid":"36361881","id":"PMC_36361881","title":"Induced Pluripotent Stem Cell (iPSC) Lines from a Family with Resistant Epileptic Encephalopathy Caused by Compound Heterozygous Mutations in SZT2 Gene.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36361881","citation_count":3,"is_preprint":false},{"pmid":"35352205","id":"PMC_35352205","title":"Genetic analysis of developmental and epileptic encephalopathy caused by novel biallelic SZT2 gene mutations in three Chinese Han infants: a case series and literature review.","date":"2022","source":"Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/35352205","citation_count":2,"is_preprint":false},{"pmid":"38134649","id":"PMC_38134649","title":"Clinical phenotype and genetic characteristics of SZT2 related diseases: A case report and literature review.","date":"2023","source":"Seizure","url":"https://pubmed.ncbi.nlm.nih.gov/38134649","citation_count":1,"is_preprint":false},{"pmid":"41357819","id":"PMC_41357819","title":"Novel SZT2::MAST2 Fusion Detected in Salivary Duct Carcinoma.","date":"2025","source":"Case reports in pathology","url":"https://pubmed.ncbi.nlm.nih.gov/41357819","citation_count":1,"is_preprint":false},{"pmid":"36531768","id":"PMC_36531768","title":"The Dysfunctional Gangway: SZT2-associated Epilepsy with Thick Corpus Callosum.","date":"2021","source":"Journal of pediatric neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/36531768","citation_count":1,"is_preprint":false},{"pmid":"41535455","id":"PMC_41535455","title":"Brain organoid models of SZT2-related disease reveal an overproduction of outer radial glial cells through mTORC1 activation.","date":"2026","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/41535455","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":14848,"output_tokens":2679,"usd":0.042364,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9869,"output_tokens":3273,"usd":0.065585,"stage2_stop_reason":"end_turn"},"total_usd":0.107949,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2017,\n      \"finding\": \"SZT2 recruits a fraction of GATOR1 and GATOR2 to form a SZT2-orchestrated GATOR (SOG) complex; the SZT2-GATOR1 and SZT2-GATOR2 interactions are synergistic, and an intact SOG complex is required for lysosomal localization of GATOR components. SZT2 deficiency results in constitutive mTORC1 signaling under nutrient-deprived conditions. Hyperactivation of mTORC1 in SZT2-deficient cells was partially corrected by overexpression of DEPDC5, lysosome-targeted WDR59, or lysosome-targeted SESN2, placing SZT2 upstream of GATOR1/2 and SESN in nutrient sensing.\",\n      \"method\": \"Co-immunoprecipitation, lysosome fractionation, genetic rescue (overexpression of GATOR1/GATOR2/SESN2 components), mouse knockout (neonatal lethality with failure to inactivate mTORC1 during fasting), cell-based mTORC1 activity assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, lysosomal fractionation, genetic epistasis with multiple components, in vivo mouse model, multiple orthogonal methods in one rigorous study\",\n      \"pmids\": [\"28199315\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Szt2 is a large (~378 kDa) protein encoded by a 72-exon gene with no significant sequence similarity to other proteins; a splice-donor mutation after exon 32 causes transcriptional read-through and premature stop, conferring low seizure threshold in mice. A gene-trap mutation in exon 21 also conferred low seizure threshold and some embryonic lethality in homozygotes, indicating a developmental role. Szt2 is highly expressed in brain and is evolutionarily conserved across land vertebrates and many invertebrates.\",\n      \"method\": \"Chemical mutagenesis screen, genetic mapping, RT-PCR (splice mutation verification), gene-trap allele phenotypic analysis\",\n      \"journal\": \"Genes, brain, and behavior\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — forward genetic screen with two independent alleles, RT-PCR validation, phenotypic characterization; no biochemical mechanism established\",\n      \"pmids\": [\"19624305\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Patient-derived lymphoblastoid cell lines (LCLs) carrying biallelic SZT2 loss-of-function mutations show increased phosphorylation of S6K and S6 under amino acid starvation, and constitutive lysosomal localization of mTOR, demonstrating that SZT2 mutations cause hyperactivation of mTORC1 in human cells. Patients' LCLs also display excessive mTORC1 response to slight amino acid stimulation.\",\n      \"method\": \"Phospho-immunoblotting (pS6K, pS6), immunofluorescence for lysosomal mTOR localization in patient-derived LCLs under amino acid starvation and stimulation conditions\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — patient-derived cell functional assay with two orthogonal readouts (phosphoblot + lysosomal localization), single lab\",\n      \"pmids\": [\"31430354\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SZT2 is required for hematopoietic stem cell (HSC) homeostasis through nutrient-mediated mTORC1 regulation. HSC-specific SZT2 ablation decreased the HSC reserve and impaired repopulating capacity. Simultaneous ablation of SZT2 and TSC1 produced a synergistic (~10-fold) increase in mTORC1 activity and ~100-fold increase in ROS production, rapidly depleting HSCs, causing pancytopenia and premature mouse death, demonstrating that nutrient-sensing (SZT2) and growth-factor-sensing (TSC1) arms of mTORC1 regulation act synergistically in stem cells.\",\n      \"method\": \"Conditional HSC-specific knockout mice, bone marrow transplantation (repopulating capacity assay), phospho-S6K/S6 immunoblotting, ROS measurement, double-knockout epistasis analysis\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with functional readout (repopulating assay), double-KO epistasis, multiple biochemical readouts, in vivo model\",\n      \"pmids\": [\"36250465\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"A functional mTORC1 assay identified SZT2 p.Val1984del as a loss-of-function variant; haplotype analysis revealed it is a founder variant in individuals of Ashkenazi Jewish ancestry. The assay platform was used to reclassify variants of uncertain significance in SZT2, confirming the protein's role in the amino acid-sensing arm of mTORC1 signaling.\",\n      \"method\": \"Cell-based mTORC1 signaling functional assay (phospho-S6K readout in SZT2-null cells re-expressing variants), haplotype analysis\",\n      \"journal\": \"Brain : a journal of neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-based functional assay with defined readout for multiple variants, single lab\",\n      \"pmids\": [\"35773235\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Systematic interactome analysis of SZT2 identified interaction partners beyond known GATOR/KICSTOR components, including proteins related to autophagy, ciliogenesis regulation, neurogenesis, and neurodegenerative processes. SZT2 KO cells showed increased mTORC1 signaling (reversible by Rapamycin or Torin) and elevated autophagic component levels independent of nutrient conditions. Preliminary data indicated SZT2 alters ciliogenesis.\",\n      \"method\": \"Affinity purification/mass spectrometry interactome analysis under catabolic and anabolic conditions, SZT2 KO cell lines with mTORC1 and autophagy marker immunoblotting, ciliogenesis assay\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — AP-MS interactome with functional validation in KO cells using multiple readouts; ciliogenesis described as preliminary, single lab\",\n      \"pmids\": [\"34685691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Patient-derived compound heterozygous Szt2 variants impair mitochondrial energy metabolism, providing the first evidence of a metabolic consequence of SZT2 loss of function beyond mTOR signaling.\",\n      \"method\": \"Metabolic profiling / mitochondrial energy metabolism assays in patient-derived cells\",\n      \"journal\": \"Clinical case reports\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single patient case, single lab, abstract does not detail specific methods or controls beyond 'metabolic profiling'\",\n      \"pmids\": [\"30564332\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"In human brain organoids derived from SZT2 mutant iPSCs, there is a significantly greater number of outer radial glial cells (oRGCs) in the SVZ-like layer and more upper-layer neurons compared to controls. SZT2 mutant organoids show higher mTORC1 activity in the SVZ, suggesting SZT2 dysfunction causes cortical expansion (and potentially macrocephaly) through mTORC1 dysregulation in neural stem/progenitor cells.\",\n      \"method\": \"iPSC-derived brain organoids from SZT2 patient lines, immunostaining for oRGC markers, mTORC1 activity readouts in SVZ-like regions\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — human organoid model with defined cellular phenotype and mTORC1 mechanistic link, single lab, new study\",\n      \"pmids\": [\"41535455\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Crystal structure simulation analysis of SZT2 missense variant c.3508A>G/p.Ser1170Gly predicted impaired binding of SZT2 to GATOR1, suggesting the Ser1170 residue is important for SZT2–GATOR1 interaction and that disruption leads to mTORC1 overactivation.\",\n      \"method\": \"In silico crystal structure simulation/molecular modeling of SZT2 missense variants\",\n      \"journal\": \"Neurological sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — computational prediction only, no experimental validation of interaction reported in abstract\",\n      \"pmids\": [\"35352205\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SZT2 is a large scaffolding protein that forms the core of the KICSTOR complex and assembles a SZT2-orchestrated GATOR (SOG) complex by simultaneously recruiting GATOR1 (a GAP for RagA/B GTPases) and GATOR2 to lysosomes, thereby enabling nutrient-sensitive downregulation of mTORC1; loss of SZT2 causes constitutive lysosomal mTOR localization and mTORC1 hyperactivation under amino acid deprivation, with demonstrated consequences in neurons (excess outer radial glia, cortical over-expansion), hematopoietic stem cells (impaired self-renewal, synergistic ROS elevation with TSC1 loss), and patient-derived lymphoblastoid cells, placing SZT2 as the critical upstream organizer of the amino acid–sensing branch of mTORC1 signaling.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SZT2 is a large scaffolding protein that organizes the amino acid-sensing branch of mTORC1 signaling by assembling a SZT2-orchestrated GATOR (SOG) complex, simultaneously recruiting GATOR1 and GATOR2 to lysosomes through synergistic interactions that are required for the lysosomal localization of GATOR components [#0]. Loss of SZT2 produces constitutive mTORC1 signaling even under nutrient-deprived conditions, and this hyperactivation can be corrected by restoring downstream nutrient-sensing components such as DEPDC5, lysosome-targeted WDR59, or lysosome-targeted SESN2, placing SZT2 upstream of GATOR1/2 and SESN [#0]. In human cells, biallelic SZT2 loss-of-function leads to constitutive lysosomal mTOR localization and elevated S6K/S6 phosphorylation under amino acid starvation, with exaggerated responses to slight amino acid stimulation [#2], and cell-based functional assays have validated specific pathogenic variants and reclassified variants of uncertain significance in this pathway [#4]. The consequences of this regulatory role are evident across cell types: SZT2 sustains hematopoietic stem cell homeostasis and self-renewal, acting synergistically with the growth-factor-sensing arm (TSC1) such that combined loss drives a ~10-fold increase in mTORC1 activity, ~100-fold increase in ROS, and rapid stem cell depletion [#3], and in human brain organoids SZT2 mutation elevates mTORC1 activity in the SVZ and expands outer radial glia and upper-layer neurons, linking SZT2 dysregulation to cortical over-expansion [#7]. SZT2 was originally identified as a brain-enriched, evolutionarily conserved protein whose mutation confers a low seizure threshold in mice [#1]. Beyond its core mTORC1 role, interactome analysis has linked SZT2 to autophagy regulation and ciliogenesis [#5].\",\n  \"teleology\": [\n    {\n      \"year\": 2009,\n      \"claim\": \"Before any biochemical role was known, forward genetics established SZT2 as a brain-enriched, conserved protein whose disruption alters neuronal excitability, framing it as a developmentally important gene.\",\n      \"evidence\": \"Chemical mutagenesis screen and gene-trap alleles in mice with genetic mapping and RT-PCR validation\",\n      \"pmids\": [\"19624305\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No molecular mechanism or biochemical activity established\", \"No protein interaction partners identified\", \"Link to mTORC1 not yet known\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"The central question of what SZT2 does molecularly was answered by showing it scaffolds GATOR1 and GATOR2 into a lysosomal SOG complex, defining SZT2 as the upstream organizer of amino acid-sensing input to mTORC1.\",\n      \"evidence\": \"Reciprocal co-IP, lysosome fractionation, genetic epistasis rescue with GATOR/SESN components, and mouse knockout with fasting-resistant mTORC1 activity\",\n      \"pmids\": [\"28199315\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No high-resolution structure of the SOG complex\", \"Stoichiometry and assembly order of SZT2-GATOR1-GATOR2 not resolved\", \"Mechanism of nutrient signal transduction through the scaffold unclear\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"A first hint that SZT2 loss has consequences beyond mTOR signaling came from a metabolic readout, raising the possibility of a mitochondrial energy role.\",\n      \"evidence\": \"Metabolic profiling / mitochondrial energy metabolism assays in patient-derived cells\",\n      \"pmids\": [\"30564332\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single patient case without detailed methods or controls\", \"Causal link between SZT2 and mitochondrial metabolism not established\", \"Not independently replicated\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"The mouse and cell-line mechanism was confirmed to operate in human disease by demonstrating constitutive lysosomal mTOR and elevated S6K/S6 phosphorylation in patient-derived cells carrying biallelic SZT2 mutations.\",\n      \"evidence\": \"Phospho-immunoblotting and immunofluorescence for lysosomal mTOR in patient LCLs under starvation and stimulation\",\n      \"pmids\": [\"31430354\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab patient-derived cell study\", \"Does not resolve which protein interactions are disrupted by specific mutations\", \"Does not connect cellular phenotype to organismal disease features\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Unbiased interactome mapping extended SZT2's reach beyond GATOR/KICSTOR, implicating it in autophagy and ciliogenesis while confirming nutrient-independent mTORC1 control in knockout cells.\",\n      \"evidence\": \"AP-MS interactome under catabolic/anabolic conditions plus mTORC1 and autophagy marker immunoblotting and ciliogenesis assays in KO cells\",\n      \"pmids\": [\"34685691\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Ciliogenesis effect described as preliminary\", \"Functional significance of non-GATOR interactors not validated\", \"Single lab\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Cell-based functional assays operationalized the mechanism for clinical genetics, identifying loss-of-function variants (including an Ashkenazi Jewish founder allele) and reclassifying variants of uncertain significance.\",\n      \"evidence\": \"Phospho-S6K readout in SZT2-null cells re-expressing variants, with haplotype analysis; complemented by in silico structural modeling of a GATOR1-binding residue\",\n      \"pmids\": [\"35773235\", \"35352205\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural prediction of Ser1170 GATOR1 binding not experimentally validated\", \"Variant assay reflects S6K readout only, not full pathway\", \"Genotype-phenotype correlation across variants incomplete\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Tissue-specific genetics revealed that SZT2 nutrient sensing is functionally critical in stem cells and acts synergistically with the growth-factor arm, defining how two mTORC1 inputs integrate physiologically.\",\n      \"evidence\": \"HSC-specific conditional knockout with bone marrow repopulation assays, SZT2/TSC1 double-KO epistasis, phospho-S6K/S6 immunoblotting, and ROS measurement\",\n      \"pmids\": [\"36250465\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of synergy with TSC1 not defined biochemically\", \"Source of the dramatic ROS elevation not mechanistically dissected\", \"Generalizability beyond HSCs unaddressed\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Human brain organoids connected SZT2-driven mTORC1 dysregulation to a specific neurodevelopmental phenotype, linking progenitor mTORC1 hyperactivity to outer radial glia expansion and cortical over-growth.\",\n      \"evidence\": \"iPSC-derived brain organoids from SZT2 patient lines with oRGC marker immunostaining and mTORC1 activity readouts in SVZ-like regions\",\n      \"pmids\": [\"41535455\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab organoid model\", \"Causal chain from mTORC1 to oRGC expansion not fully dissected\", \"Relationship to human macrocephaly remains inferential\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How SZT2 transduces nutrient signals through the SOG scaffold at atomic resolution, and whether its autophagy, ciliogenesis, and mitochondrial links are direct or downstream of mTORC1, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No experimental structure of SZT2 or the SOG complex\", \"Direct versus indirect basis of non-mTOR functions unknown\", \"Mechanism coupling amino acid status to GATOR1/2 regulation undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 3]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [5]}\n    ],\n    \"complexes\": [\"KICSTOR\", \"SZT2-orchestrated GATOR (SOG) complex\"],\n    \"partners\": [\"DEPDC5\", \"WDR59\", \"SESN2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}